Compile Data Set for Download or QSAR
maximum 50k data
Found 69 Enz. Inhib. hit(s) with all data for entry = 10046
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510809(US11078192, Compound 68)
Affinity DataIC50:  18nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510810(US11078192, Compound 69)
Affinity DataIC50:  36nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510787(US11078192, Compound 46)
Affinity DataIC50:  48nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510786(US11078192, Compound 45)
Affinity DataIC50:  49nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510734(US11078192, Compound 7)
Affinity DataIC50:  50nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510785(US11078192, Compound 44)
Affinity DataIC50:  59nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510736(US11078192, Compound 9)
Affinity DataIC50:  60nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510732(US11078192, Compound 5)
Affinity DataIC50:  60nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510798(US11078192, Compound 57)
Affinity DataIC50:  70nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510735(US11078192, Compound 8)
Affinity DataIC50:  80nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510781(US11078192, Compound 40)
Affinity DataIC50:  90nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510777(US11078192, Compound 36)
Affinity DataIC50:  100nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510778(US11078192, Compound 37)
Affinity DataIC50:  100nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510797(US11078192, Compound 56)
Affinity DataIC50:  100nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510803(US11078192, Compound 62)
Affinity DataIC50:  120nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510784(US11078192, Compound 43)
Affinity DataIC50:  130nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510733(US11078192, Compound 6)
Affinity DataIC50:  150nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510780(US11078192, Compound 39)
Affinity DataIC50:  170nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510737(US11078192, Compound 10)
Affinity DataIC50:  170nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510746(US11078192, Compound 18)
Affinity DataIC50:  190nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510779(US11078192, Compound 38)
Affinity DataIC50:  230nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510743(US11078192, Compound 15)
Affinity DataIC50:  240nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510772(US11078192, Compound 31)
Affinity DataIC50:  240nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510741(US11078192, Compound 13)
Affinity DataIC50:  240nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510773(US11078192, Compound 32)
Affinity DataIC50:  250nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510776(US11078192, Compound 35)
Affinity DataIC50:  250nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510731(US11078192, Compound 4)
Affinity DataIC50:  280nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510745(US11078192, Compound 17)
Affinity DataIC50:  310nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510751(US11078192, Compound 19)
Affinity DataIC50:  330nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510775(US11078192, Compound 34)
Affinity DataIC50:  340nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510742(US11078192, Compound 14)
Affinity DataIC50:  390nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510740(US11078192, Compound 12)
Affinity DataIC50:  410nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510771(US11078192, Compound 30)
Affinity DataIC50:  460nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510738(US11078192, Compound 11)
Affinity DataIC50:  460nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510774(US11078192, Compound 33)
Affinity DataIC50:  480nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510763(US11078192, Compound 22)
Affinity DataIC50:  550nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510744(US11078192, Compound 16)
Affinity DataIC50:  590nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510764(US11078192, Compound 23)
Affinity DataIC50:  690nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510755(US11078192, Compound 21)
Affinity DataIC50:  780nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510792(US11078192, Compound 51)
Affinity DataIC50:  815nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510768(US11078192, Compound 27)
Affinity DataIC50:  920nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510788(US11078192, Compound 47)
Affinity DataIC50:  920nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510783(US11078192, Compound 42)
Affinity DataIC50:  1.10E+3nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510767(US11078192, Compound 26)
Affinity DataIC50:  1.30E+3nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510728(US11078192, Compound 2)
Affinity DataIC50:  1.34E+3nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510727(US11078192, Compound 1)
Affinity DataIC50:  1.53E+3nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510806(US11078192, Compound 65)
Affinity DataIC50:  2.00E+3nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510769(US11078192, Compound 28)
Affinity DataIC50:  2.16E+3nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510808(US11078192, Compound 67)
Affinity DataIC50:  2.40E+3nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProgrammed cell death 1 ligand/protein 1(Homo sapiens)
TBA

US Patent
LigandPNGBDBM510729(US11078192, Compound 3)
Affinity DataIC50:  2.70E+3nMAssay Description:1. The compound was formulated to 10 concentrations with a 3-fold gradient with 100% DMSO.2. The solution of the compound in DMSO was added to Dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 69 total ) | Next | Last >>
Jump to: